(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Quarter results tomorrow
(bmo 2024-04-29)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs...
Stats | |
---|---|
Dagens volum | 1 786.00 |
Gjennomsnittsvolum | 4 092.00 |
Markedsverdi | 111.50M |
EPS | €0 ( 2024-04-09 ) |
Neste inntjeningsdato | ( €0 ) 2024-04-29 |
Last Dividend | €1.200 ( 2023-07-19 ) |
Next Dividend | €0 ( N/A ) |
P/E | 11.57 |
ATR14 | €0.511 (2.41%) |
Volum Korrelasjon
HAEMATO AG Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
HAEMATO AG Korrelasjon - Valuta/Råvare
HAEMATO AG Økonomi
Annual | 2022 |
Omsetning: | €248.14M |
Bruttogevinst: | €15.30M (6.17 %) |
EPS: | €1.570 |
FY | 2022 |
Omsetning: | €248.14M |
Bruttogevinst: | €15.30M (6.17 %) |
EPS: | €1.570 |
FY | 2021 |
Omsetning: | €285.04M |
Bruttogevinst: | €30.73M (10.78 %) |
EPS: | €2.74 |
FY | 2020 |
Omsetning: | €238.33M |
Bruttogevinst: | €17.69M (7.42 %) |
EPS: | €-2.02 |
Financial Reports:
No articles found.
HAEMATO AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€1.100 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€1.200 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €2.50 | 2011-08-26 |
Last Dividend | €1.200 | 2023-07-19 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | €26.30 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.59 | -- |
Div. Sustainability Score | 9.35 | |
Div.Growth Potential Score | 3.85 | |
Div. Directional Score | 6.60 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TIMA.DE | Ex Dividend Junior | 2023-05-10 | Annually | 0 | 0.00% | |
DMP.DE | Ex Dividend Knight | 2023-06-15 | Annually | 0 | 0.00% | |
MTE.DE | Ex Dividend Junior | 2023-07-07 | Quarterly | 0 | 0.00% | |
68V.DE | Ex Dividend Knight | 2023-08-07 | Quarterly | 0 | 0.00% | |
WAF.DE | Ex Dividend Junior | 2023-05-08 | Annually | 0 | 0.00% | |
FIE.DE | Ex Dividend Junior | 2023-07-14 | Annually | 0 | 0.00% | |
PAH3.DE | Ex Dividend Knight | 2023-07-03 | Annually | 0 | 0.00% | |
AP2.DE | Ex Dividend Knight | 2023-11-22 | Quarterly | 0 | 0.00% | |
HDI.DE | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
RWE.DE | Ex Dividend Junior | 2023-05-05 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0368 | 1.500 | 9.26 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0524 | 1.200 | 8.25 | 9.90 | [0 - 0.3] |
returnOnEquityTTM | 0.0648 | 1.500 | -0.391 | -0.587 | [0.1 - 1] |
payoutRatioTTM | 0.598 | -1.000 | 4.02 | -4.02 | [0 - 1] |
currentRatioTTM | 2.46 | 0.800 | 2.68 | 2.14 | [1 - 3] |
quickRatioTTM | 1.574 | 0.800 | 5.45 | 4.36 | [0.8 - 2.5] |
cashRatioTTM | 0.444 | 1.500 | 8.64 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0169 | -1.500 | 9.72 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 15.84 | 1.000 | 5.24 | 5.24 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.22 | 2.00 | 9.26 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.01 | 2.00 | 8.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0207 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0552 | 1.000 | -2.41 | -2.41 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0351 | 1.000 | -1.297 | -1.297 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.73 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.422 | 0.800 | 3.86 | 3.08 | [0.5 - 2] |
Total Score | 9.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.60 | 1.000 | 8.93 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0648 | 2.50 | -0.251 | -0.587 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.01 | 2.00 | 9.33 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.61 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.22 | 2.00 | 9.26 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.598 | 1.500 | 4.02 | -4.02 | [0 - 1] |
pegRatioTTM | 0.0521 | 1.500 | -2.99 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0443 | 1.000 | -1.393 | 0 | [0.1 - 0.5] |
Total Score | 3.85 |
HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.